HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early patency rates after the two-suture invagination technique of vaso-epididymal anastomosis for idiopathic obstruction.

AbstractOBJECTIVES:
To prospectively evaluate the results of vaso-epididymostomy, using a two-suture microsurgical invagination technique, when used for men with azoospermia due to an obstruction at the vaso-epididymal junction.
PATIENTS AND METHODS:
Between December 2002 and November 2004, 29 men with idiopathic obstructive azoospermia underwent vaso-epididymostomy with the two-suture invagination technique. The patency rate was assessed by return of sperm in the semen after surgery.
RESULTS:
In all, 23 men provided at least one postoperative semen sample. The mean (range) follow-up was 7.6 (1.5-30) months. In 11 of these men (48%), patency was shown at a mean of 3.2 (1.5-7) months after surgery. The median sperm density was 17 (10-65) million/mL. Four men had normal sperm density and motility (>20 million/mL; >50% total motility).
CONCLUSIONS:
Men with idiopathic vaso-epididymal junction obstruction can have significant sperm positivity after vaso-epididymostomy. With a patency rate of nearly half within a year of surgery, vaso-epididymostomy should be the first line of therapy for these men.
AuthorsRajeev Kumar, Gagan Gautam, Narmada P Gupta
JournalBJU international (BJU Int) Vol. 97 Issue 3 Pg. 575-7 (Mar 2006) ISSN: 1464-4096 [Print] England
PMID16469029 (Publication Type: Evaluation Study, Journal Article)
Topics
  • Adult
  • Anastomosis, Surgical (methods)
  • Epididymis (surgery)
  • Follow-Up Studies
  • Humans
  • Male
  • Microsurgery (methods)
  • Oligospermia (surgery)
  • Prospective Studies
  • Semen (chemistry)
  • Sperm Count
  • Sperm Motility
  • Suture Techniques
  • Treatment Outcome
  • Vas Deferens (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: